Skip to search formSkip to main contentSkip to account menu

ATI 7505

Known as: ATI-7505, ATI7505, naronapride 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

BenzamidesQuinuclidinesSerotonin 5-HT4 Receptor Agonists

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Current developments in pharmacological therapeutics for chronic constipation
Review
2014
Review
2014
5-HT4 Receptor Agonists in the Treatment of Gastrointestinal Motility Disorders: Current Status and Perspective
Background: 5-HT4 receptor plays important roles regulating gastrointestinal motility, enteric neuronal signaling and visceral… 
Review
2013
Review
2013
Pathophysiology and pharmacotherapy of gastroparesis: current and future perspectives
Introduction: Gastroparesis is an important clinical disorder characterised by delayed gastric emptying in the absence of… 
2011
2011
Molecular Pharmacology of Naronapride, a Selective 5-HT4 Receptor Agonist for the Treatment of Constipation: Comparison With Other Prokinetic 5-HT4 Receptor Agonists
2011
2011
A Multi-Center, Double-Blind, Parallel-Group Study to Evaluate Short-Term Safety and Efficacy and Long-Term Maintenance of Two Dose Levels of Rabeprazole Sodium Delayed-Release Pediatric Bead…
2010
2010
Reply
to the capsulorhexis Miayke et al. described the long-term clinical outcomes of toric intraocular lens (IOL) implantation in… 
2010
2010
906 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Lubiprostone for the Treatment of Opioid-Induced Bowel Dysfunction in Patients With Chronic, Non-Cancer Pain
Review
2009
Review
2009
Translating 5‐HT4 receptor pharmacology
Abstract  Since metoclopramide was first described (in 1964) there have been several attempts to develop compounds which retained… 
2009
2009
Translating 5-HT 4 receptor pharmacology
Since metoclopramide was first described (in 1964) there have been several attempts to develop compounds which retained… 
Highly Cited
2007
Highly Cited
2007
Pharmacodynamic effects of a novel prokinetic 5‐HT4 receptor agonist, ATI‐7505, in humans
Abstract  ATI‐7505, an investigational 5‐HT4 receptor agonist, was designed to have similar activity as cisapride without the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)